New COVID Drug Is So Successful Researchers Shut Down Trials Early [VeryWell Health]

Published April 19, 2022

VeryWell Health interviewed Thomas A. Russo, MD, SUNY Distinguished Professor of medicine and chief of the Division of Infectious Diseases, in an article about the success of sabizabulin, a drug that has the potential to half the risk of death for people with moderate and severe forms of COVID-19. Sabizabulin helps tamp down on an important part of the virus replicating in the body. “When the virus enters the cell, a variety of steps need to occur,” said Russo. “One of those is that it needs to move within the cell from one compartment to the other. This drug interferes with the process.”